Image

State of Play of Non-tuberculous Mycobacteria in Alsace

State of Play of Non-tuberculous Mycobacteria in Alsace

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

Non-tuberculous mycobacteriosis (NTM) are infectious diseases caused by mycobacteria that are not part of the Tuberculosis complex. More than 190 species have been identified to date.

As an environmental reservoir, it most often affects the lungs, skin and soft tissues, lymph nodes, but it can affect all organs. Varying in virulence depending on the species, most infections do not cause illness.

There is currently no coordinated care pathway for this pathology in Alsace. The means necessary to set up such a structure requires knowing the importance of the disease.

Description

The aim of the study is to determine the incidence of non-tuberculous mycobacterial infections in the ALSACE region, the proportion of cases in which the infection causes illness, and its evolution over time.

Eligibility

Inclusion Criteria:

  • Adult subject (≥ 18 years old)
  • in whom a biological sample is culture positive for a non-tuberculous mycobacterium
  • born in France and domiciled in Alsace (i.e. whose home postal code begins with 67 or 68)
  • not opposing the reuse of its data for scientific research purposes

Exclusion Criteria:

  • Subject having expressed opposition to participating in the study
  • not domiciled in Alsace
  • Born abroad
  • Isolation of a mycobacterium from the Tuberculosis complex and Mycobacterium gordonae

Study details
    Non-Tuberculous Mycobacteria

NCT06185166

University Hospital, Strasbourg, France

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.